A comparative study on anti-cancer potentials of the tamarixetin and quercitrin on Luminal A Breast Cancer

  • سال انتشار: 1403
  • محل انتشار: دومین کنگره بین المللی کنسرژنومیکس
  • کد COI اختصاصی: ICGCS02_048
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 140
دانلود فایل این مقاله

نویسندگان

Farshid Aaliazar

Department of Biology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran

Laleh Arzi

Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran

چکیده

Hormone blocking therapy is a conventional and established remedy to treat the more frequent subtype of breast cancers, Luminal A. However, about ۲۰-۳۰% of tumors are resistant to hormone therapy. Phytotherapeutic agents displayed prophylactic and therapeutic roles in breast malignancies. Tamarixetin, a natural O methylated flavonol, exhibited anti inflammatory, cardiotonic, gastroprotective properties and mediated the suppression multi drug resistance proteins. Howbeit, studies on its anticancer potentials are still inadequate. The present survey is a comparative evaluation of the molecular docking of Tamarixetin / Quercitrin to the apoptosis mediated proteins. Based on which, the cytotoxicity and apoptosis induction potency of the more favorable flavonoid, on MCF ۷ cancer cells were assessed. Methods: The in silico interaction of Tamarixetin and Quercitrin apoptosis associated proteins (p۲۱, p۵۳, caspase ۸, bax, and bcl۲) were evaluated by molecular docking. The MCF ۷ cells treated with various concentrations of Tamarixetin (۰-۵۰µg/ml) for ۲۴ and ۴۸ h and cell viability was evaluated by MTT assay. The pro apoptotic potential of Tamarixetin (۲۵µg/ml) for ۲۴ h on MCF ۷ cells were assessed by Annexin V/PI flow cytometry assay. The expression levels of p۵۳, p۲۱, caspase ۸, SOD۱ and SOD۲ were measured by Real time PCR. Results: It was found that treatment of MCF ۷ cells with Tamarixetin engenders a decrease in viability in a time and dose dependent manner. Tamarixetin induced early and late apoptosis in MCF ۷ cells was demonstrated via flowcytometry. Gene expression analysis affirmed that Tamarixetin exerted pro apoptotic potential through activation of the extrinsic pathway of apoptosis via activation of caspase ۸, and the intrinsic pathway of apoptosis by stimulation of p۵۳ and its essential downstream target, p۲۱. This flavonol enhanced the expression of antioxidant enzymes (SOD۱ and SOD۲) independently, or dependent on p۵۳. Conclusion: The findings of this research propose Tamarixetin as an auspicious complementary anticancer herbal medicine for therapy of Luminal A breast cancer.

کلیدواژه ها

Tamarixetin, Luminal A, anti proliferative, pro apoptotic

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.